Review of Optometry - Have beta-blockers breathed their last? Beta-blockers are a mainstay of therapy. But we monitor pulmonary function for safety.(Glaucoma Grand Rounds)
A 61-year-old black female glaucoma patient, previously managed with beta-blockers, requires medical intervention for airway obstructive disease.
[ILLUSTRATION OMITTED]
The patient initially presented to me in 1997 at age 54 with a diagnosis of open-angle glaucoma O.U., for which she was medicated with Betoptic S (betaxolol, Alcon) 1 drop qhs O.U. She had been on this regimen for about five years prior.
n Related Results
Trust, E-innovation and Leadership in ChangeForeign Banks in United States Since World War II: A Useful FringeBuilding Your Brand With Brand Line ExtensionsThe Impact of the Structure of Debt on Target GainsProject Management Standard Program
She also was on both Calan (verapamil, Pfizer) qd and Lasix (furosemide, Aventis) qd to control hypertension. She reported no allergies to medications. Family history …
Read the rest of this article with a Free Trial at HighBeam Research.
